Replies to post #820230 on NorthWest Biotherapeutics Inc (NWBO)

[DrHigh]

that is great for cancer patients that there are other competently run BP companies progressing with treatments. Sadly this has nothing to do with NWBO

[manibiotech]

How does this has anything to do with DcVax ?? This helps patients in HK get access to medicines available in US . And as far as we know DcVax is not approved in US . So help us understand why are you so excited ?

[bas2020]

We are already seeing the impact of this shift, with vorasidenib – the first new treatment for adult brain tumours in the UK for 2 decades – now available to eligible patients on the NHS. We are hopeful that this will unlock further innovative treatments and ensure more promising drugs clear the threshold for approval, opening up new opportunities and better outcomes for brain tumour patients.

[JTORENCE]

As usual, not even a peep about DCVAX. NWBO being a U.S. company, puts them at the bottom of the list.
So obvious they (MHRA) are bias against U.S. companies. imo

[beartrap12]

MWarlock, This treatment is NOT recommended for GBM, but for low-grade gliomas. Here's what the company recommends:
VORANIGO (40 mg tablets) is indicated for the treatment of adult and pediatric patients 12 years and older with Grade 2 astrocytoma or oligodendroglioma with a susceptible isocitrate dehydrogenase-1 (IDH1) or isocitrate dehydrogenase-2 (IDH2) mutation, as detected by an FDA-approved test, following surgery including biopsy, sub-total resection, or gross total resection.
So it appears not to be in competition with DCVax-L.